Guided Therapeutics (GTHP) Receivables - Other (2018 - 2022)
Guided Therapeutics recorded quarterly Receivables - Other of $82984.0 in Q4 2022, up 92.73% quarter-over-quarter from $43057.0 in Q3 2022.
Guided Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $82984.0 for Q4 2022.
- In Q4 2022, Receivables - Other changed N/A year-over-year to $82984.0; the TTM figure through Dec 2022 stood at $82984.0 (changed N/A YoY), while the FY2022 annual figure was $82984.0, changed N/A from the prior year.
- Receivables - Other came in at $82984.0 for Q4 2022 at Guided Therapeutics, up from $43057.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $661000.0 in Q3 2018 to a low of $24785.0 in Q2 2022.
- A 3-year average of $173637.7 and a median of $91492.0 in 2020 frame the typical range for Receivables - Other.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 82,984.00 |
| Dec 31, 2022 | 82,984.00 |
| Sep 30, 2022 | 43,057.00 |
| Sep 30, 2022 | 43,057.00 |
| Jun 30, 2022 | 24,785.00 |
| Jun 30, 2022 | 24,785.00 |
| Mar 31, 2022 | 130,000.00 |
| Mar 31, 2022 | 130,000.00 |
| Mar 31, 2020 | 100,000.00 |
| Mar 31, 2020 | 100,000.00 |
| Sep 30, 2018 | 661,000.00 |
| Sep 30, 2018 | 661,000.00 |